Research: Making the biotech IPO work
There were more biotech IPOs in 2012-13 than in a y previous IPO window. Will these companies be able to deliver of their promise of new generations of therapeutic products and economic growth? A recent paper from the Center for Integration of Science and Industry provides a prescription for success that will require strategic business models and patience. Listen to interview on Bloomberg Radio.
Research: Why commercialization of gene therapy stalled
It has been 40 years since recombinant technologies first enabled consideration of gene therapy for human disease, and 30 years since the first gene therapy companies were formed. Yet, there are no gene therapies on the market in the US or EU. A recent research paper from the Center for Integration of Science and Industry explores how asynchrony between capital investments and the maturation of gene therapy technologies may have contributed to this delay.
Bentley Receives $1.3M to Advance the Integration of Science and Business
The National Biomedical Research Foundation has awarded a $1.3M grant to Bentley University to establish a Center for Integration of Science and Industry, under the direction of Dr. Fred Ledley, Professor of Natural & Applied Sciences and Management. The mission of the Center will be to understand the process involved in scientific discovery leading to public value, and accelerate this process by engaging science and industry in interdisciplinary dialogue, scholarship, and education.